Sponsor Pipeline

Evergreen Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
0
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05077215 Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in… Advanced Endometrial Cancer Not Yet Recruiting
Phase 2
NCT05106127 Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem Advanced Endometrial Cancer Not Yet Recruiting
NCT05170048 Study to Evaluate Safety and Efficacy of EG-301 in Patients With Nonfocal Geographic… Non-Exudative (Dry) Age-related Macular Degeneration (dAMD) Not Yet Recruiting
Phase 1
NCT07327255 Pharmacokinetic Study to Evaluate Safety and Tolerability of EG-101 in Healthy Female… Pre-eclampsia Not Yet Recruiting
Disease Areas
Get alerts when Evergreen Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free